|
2,024
|
| 16237 |
Coxiella burnetii, phase I
|
|
increases_quantity of
|
TNF
|
in infected monocytes
|
| 16238 |
TNF
|
|
decreases_activity of
|
pathogen survival
|
in THP-1 infected monocytes
|
|
21030501
|
Q fever
|
|
2,103
|
| 17208 |
M1 polarization
|
|
increases_quantity of
|
TNF
|
in macrophages
|
| 34979 |
atypical M2 polarization
|
NOT |
increases_quantity of
|
TNF
|
in macrophages
|
|
19538264
|
Q fever
|
|
2,123
|
| 17537 |
exoS
|
|
increases_quantity of
|
TNF
|
|
| 17551 |
pcrV
|
|
increases_quantity of
|
TNF
|
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
|
2,214
|
| 18809 |
N-(3-Oxododecanoyl)-HSL
|
|
decreases_quantity of
|
TNF
|
|
|
18704225
|
Pseudomonas aeruginosa diseases
|
|
2,791
|
| 25817 |
exoU
|
|
increases_quantity of
|
TNF
|
|
|
21819560
|
Pseudomonas aeruginosa diseases
|
|
2,905
|
| 26666 |
P. aeruginosa infection
|
|
increases_expression of
|
TNF
|
|
| 26709 |
Miglustat
|
|
decreases_expression of
|
TNF
|
up-regulated by P. aeruginosa
|
| 26723 |
Amitriptyline
|
|
decreases_expression of
|
TNF
|
up-regulated by P. aeruginosa
|
|
21659660
|
Pseudomonas aeruginosa diseases
|
|
2,906
|
| 26667 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
TNF
|
|
|
21659660
|
Pseudomonas aeruginosa diseases
|
|
3,307
|
| 30373 |
2-Heptyl-4-quinolone, HHQ
|
|
decreases_expression of
|
TNF
|
in J774A.1 and primary BAL cells
|
| 30378 |
2-Heptyl-3-hydroxy-4-quinolone, PQS
|
|
decreases_expression of
|
TNF
|
in J774A.1 and primary BAL cells
|
|
20102415
|
Pseudomonas aeruginosa diseases
|
|
3,572
|
| 33398 |
Coxiella burnetii, phase I
|
|
increases_quantity of
|
TNF
|
in HMDM cells
|
| 33399 |
Coxiella burnetii, phase II
|
|
increases_quantity of
|
TNF
|
in HMDM cells
|
|
20515926
|
Q fever
|
|
3,573
|
| 33781 |
TNF
|
|
increases_quantity of
|
NOS2
|
|
|
22711626
|
Q fever
|
|
3,577
|
| 33503 |
aaaA
|
|
increases_quantity of
|
TNF
|
shown by qRT-PCR analysis, 2 days post infection
|
|
22927813
|
Pseudomonas aeruginosa diseases
|
|
3,653
|
| 34773 |
M1 polarization
|
|
increases_quantity of
|
TNF
|
in monocytes; in response to C. burnetii infection
|
| 34788 |
atypical M2 polarization
|
NOT |
increases_quantity of
|
TNF
|
in macrophages; in response to C. burnetii infection
|
| 34813 |
IL10
|
|
decreases_quantity of
|
TNF
|
in monocytes
|
|
22711638
|
Q fever
|
|
3,660
|
| 34928 |
atypical M2 polarization
|
NOT |
increases_quantity of
|
TNF
|
in macrophages; in response to C. burnetii infection
|
| 34936 |
M1 polarization
|
|
increases_quantity of
|
TNF
|
in monocytes; in response to C. burnetii infection
|
|
18768823
|
Q fever
|
|
3,688
|
| 35425 |
IFNG
|
|
increases_quantity of
|
TNF
|
|
| 35429 |
TNF
|
|
increases_activity of
|
host cell apoptosis
|
of C. burnetii-infected macrophages
|
| 35430 |
TNF
|
|
decreases_activity of
|
pathogen survival
|
of C. burnetii-infected macrophages
|
|
22711637
|
Q fever
|
|
3,868
|
| 38927 |
P. aeruginosa infection
|
|
increases_quantity of
|
TNF
|
in BAL fluids of mice
|
| 38929 |
CYBB
|
|
increases_quantity of
|
TNF
|
in BAL fluids of mice
|
| 38941 |
NOX4
|
NOT |
affects_quantity of
|
TNF
|
in BAL fluids of mice
|
|
23306835
|
Pseudomonas aeruginosa diseases
|
|
4,001
|
| 40993 |
ELANE
|
|
increases_expression of
|
TNF
|
in cell free BALs (bronchoalveolar lavage), in J774 murine macrophages and in whole lung tissues; in response to P. aeruginosa infection
|
| 40995 |
ELANE
|
|
increases_quantity of
|
TNF
|
in cell free BALs (bronchoalveolar lavage), in J774 murine macrophages and in whole lung tissues; in response to P. aeruginosa infection
|
|
22927440
|
Pseudomonas aeruginosa diseases
|
|
4,565
|
| 45540 |
N-(3-Oxododecanoyl)-HSL
|
|
decreases_quantity of
|
TNF
|
in LPS-stimulated RAW264.7 macrophages
|
|
23720811
|
Pseudomonas aeruginosa diseases
|
|
6,616
|
| 63014 |
Pyocyanine
|
|
increases_expression of
|
TNF
|
|
| 63020 |
Pyocyanine
|
|
increases_quantity of
|
TNF
|
|
| 63024 |
TNF
|
|
increases_quantity of
|
MUC5AC
|
|
|
20962773
|
Pseudomonas aeruginosa diseases
|
HoPaCI